Drug trouble.Drug Trouble: Amgen Inc. received an inquiry from the Securities and Exchange Commission requesting more information about a delay in the release of a Danish study that raised questions about the safety of its blockbuster drug A blockbuster drug is a drug generating more than $1 billion of revenue for its owner each year. The search for blockbusters has been the foundation of the R&D strategy adopted by big pharmaceutical companies, but this looks set to change. Aranesp. The study found that cancer patients taking Aranesp had a higher recurrence recurrence /re·cur·rence/ (-ker´ens) the return of symptoms after a remission.recur´rent re·cur·rence n. 1. of their tumors than those not taking the drug. Amgen said it notified the Food and Drug Administration but didn't report the results publicly. Aranesp is Amgen's best-selling best·sell·er also best seller n. A product, such as a book, that is among those sold in the largest numbers. best drug with sales topping $4 billion in 2006 and is prescribed to battle anemia associated with chemotherapy and kidney dialysis Dialysis, Kidney Definition Dialysis treatment replaces the function of the kidneys, which normally serve as the body's natural filtration system. . |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion